By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
New FDA Guidance On PDURS Ushers In A New Era for Digital Innovation In Life Sciences
This deep dive explores how the FDA’s draft PDURS guidance enables pharma companies to integrate digital solutions into their products, enhancing patient engagement and adherence. We cover the opportunities this brings for improving patient outcomes, how PDURS supports value-based healthcare, and the role of digital tools in creating a competitive edge in a crowded market.
by
Emilia Kruzel, PhD and Brooke Mastrorio
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.